What is Pomide 2mg (POMALIDOMIDE)?
Third-generation IMiD for relapsed/refractory multiple myeloma after prior lenalidomide and proteasome inhibitor treatment, and AIDS-related Kaposi sarcoma.
How it Works
Most potent IMiD — binds CRBN E3 ligase more potently than lenalidomide. Enhanced NK and T-cell immune activation against myeloma cells.
Quick Specs
| Form | Oral tablets — pre-dosed |
| Active Ingredient | POMALIDOMIDE |
| Dose per Tablet | 2MG |
| Pack Size | 105 tablets |
| Storage | Room temperature (15–25°C), cool dry place |
| Shelf Life | 2–3 years (properly stored) |
Common Side Effects
Profound myelosuppression (neutropenia), DVT/PE, fatigue, constipation, peripheral neuropathy, infections.
Safety Warnings
⚠️ TERATOGENIC — mandatory REMS. DVT/PE prophylaxis mandatory. CBC monitoring weekly. Dose reduction in renal impairment.
🌏 International shipping: 7–14 days
